Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia

Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia

INTRODUCTION: Schizophrenia, although a debilitating mental illness, greatly affects individuals physical health as well. One of the leading somatic comorbidities associated with schizophrenia is cardiovascular disease, which has been estimated to be one of the leading causes of excess mortality in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Anna I. Tkachev, Elena A. Stekolshchikova, Anna Yu. Morozova, Nikolay A. Anikanov, Yana A. Zorkina, Polina N. Alekseyeva, Elena B. Khobta, Denis S. Andreyuk, Svetlana A. Zozulya, Alexandra N. Barkhatova, Tatiana P. Klyushnik, Alexander M. Reznik, Georgiy P. Kostyuk, Philipp E. Khaitovich
Format: article
Langue:EN
RU
Publié: Eco-Vector 2021
Sujets:
ceramide
schizophrenia
cardiovascular disease
lipid
blood plasma
Psychiatry
RC435-571
Psychology
BF1-990
Accès en ligne:https://doaj.org/article/469e7b26d5674e168ba9c2677ee37fea
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/469e7b26d5674e168ba9c2677ee37fea

Documents similaires